Literature DB >> 6151117

Affinities of some common opioid analgesics towards four binding sites in mouse brain.

A Neil.   

Abstract

The selectivities of morphine, codeine, l-methadone and d-propoxyphene, towards the binding sites in mouse brain membranes labelled by 3H-dihydromorphine (DHM), 3H-ethylketocyclazocine (EKC) and 3H-D-Ala2-Leu5-enkephalin (DALE), were investigated. Of the four binding sites identified, three correspond to mu-, kappa- and delta-opioid binding sites or receptors, respectively. The fourth site has a high capacity and binds EKC with a high affinity, DHM with a very low affinity and does not bind DALE. In displacement studies, the relative affinities of morphine and methadone were quite similar towards the tree sites with highest affinity (mu much greater than kappa much greater than delta). Codeine and d-propoxyphene were mu-selective but did not differentiate between kappa- and delta-sites. At high concentrations I-methadone (Kd=6.7 microM), and d-propoxyphene (Kd=40 microM) bound to the fourth site, while morphine, codeine and naloxone were practically inactive. The binding selectivities of these drugs were quite different from those of metkephamid and U-50, 488 H, substances that are thought to exert their antinociceptive effects through delta- and kappa-receptors, respectively. It was concluded that while d-propoxyphene and codeine may partly act through other receptors than morphine, this is probably not the case for l-methadone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151117     DOI: 10.1007/BF00496100

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

3.  Characterization of opioid receptors in nervous tissue.

Authors:  H W Kosterlitz; S J Paterson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-10-29

4.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites.

Authors:  R S Zukin; S R Zukin
Journal:  Mol Pharmacol       Date:  1981-09       Impact factor: 4.436

5.  Are there subtypes (isoreceptors) of multiple opiate receptors in the mouse vas deferens?

Authors:  R Schulz; M Wüster
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

6.  Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity.

Authors:  R C Frederickson; E L Smithwick; R Shuman; K G Bemis
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

7.  An improved foot-shock titration procedure in rats for centrally acting analgesics.

Authors:  A Neil; L Terenius
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-02

8.  Properties of a selective kappa agonist, U-50,488H.

Authors:  R A Lahti; P F VonVoigtlander; C Barsuhn
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

9.  Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites.

Authors:  G S Ling; G W Pasternak
Journal:  Brain Res       Date:  1983-07-18       Impact factor: 3.252

10.  Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Authors:  H W Kosterlitz; S J Paterson; L E Robson
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more
  5 in total

Review 1.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

2.  Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.

Authors:  G Cano; J L Arcaya; G Gómez; W Maixner; H Suarez-Roca
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

3.  Subjective and behavioral responses to intravenous fentanyl in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; J G Zaragoza; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Study of the clomipramine-morphine interaction in the forced swimming test in mice.

Authors:  A Eschalier; J Fialip; O Varoquaux; M C Makambila
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate.

Authors:  Ferenc Zádor; Amir Mohammadzadeh; Mihály Balogh; Zoltán S Zádori; Kornél Király; Szilvia Barsi; Anna Rita Galambos; Szilvia B László; Barbara Hutka; András Váradi; Sándor Hosztafi; Pál Riba; Sándor Benyhe; Susanna Fürst; Mahmoud Al-Khrasani
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.